Revising expectations from rapid HIV tests in the emergency department.
Revising expectations from rapid HIV tests in the emergency department.
复制标题
DOI：
10.7326/0003-4819-149-3-200808050-00003
复制
发表时间：
2008-08-05
影响因子：
39.2
通讯作者：
Losina E
中科院分区：
文献类型：
--
作者：
Walensky RP;Arbelaez C;Reichmann WM;Walls RM;Katz JN;Block BL;Dooley M;Hetland A;Kimmel S;Solomon JD;Losina E
Expanded HIV screening efforts in the United States have increased the use of rapid HIV tests in emergency departments. The reported sensitivity and specificity of rapid HIV tests exceed 99%. To assess whether a reactive rapid oral HIV test result correctly identifies adults with HIV infection in the emergency department. Diagnostic test performance assessment within the framework of a randomized, clinical trial. Brigham and Women's Hospital emergency department (Boston, Massachusetts) from 7 February to 1 October 2007. 849 adults with valid rapid oral HIV test results. Rapid HIV testing with the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test (OraSure Technologies, Bethlehem, Pennsylvania). Patients with reactive rapid test results were offered enzyme-linked immunoassay, Western blot, and plasma HIV-1 RNA testing for confirmation. Specificity and positive likelihood ratio. 39 patients had reactive results (4.6% [95% CI, 3.2% to 6.0%]). On confirmation, 5 patients were HIV-infected (prevalence, 0.6% [CI, 0.1% to 1.1%]) and 26 were non–HIV-infected (8 patients declined confirmation). The estimated rapid test specificity was 96.9% (CI, 95.7% to 98.1%). Sensitivity analyses of the true HIV status of unconfirmed cases and test sensitivity resulted in a positive likelihood ratio of 8 to 32. Western blot alone as a confirmation test provided conclusive HIV status in only 50.0% (CI, 30.8% to 69.2%) of patients at first follow-up. The addition of HIV-1 RNA testing to the confirmation protocol improved this rate to 96.2% (CI, 88.8% to 100.0%). Test sensitivity cannot be assessed because nonreactive OraQuick test results were not confirmed. Although patients with a reactive oral OraQuick HIV screening test in the emergency department had an 8- to 32-fold increased odds of HIV infection compared with the pretest odds, the specificity of the test was lower than anticipated.
登录
查看更多内容
影响因子：
4.4
作者：
Wuerz, RC;Travers, D;Yazhari, R
通讯作者：
Yazhari, R
影响因子：
120.7
作者：
KERLIKOWSKE, K;GRADY, D;ERNSTER, V
通讯作者：
ERNSTER, V
影响因子：
4.4
作者：
Mehta, Supriya D.;Hall, Jonathan;Kharasch, Sigmund
通讯作者：
Kharasch, Sigmund
影响因子：
4.4
作者：
Eitel, DR;Travers, DA;Wuerz, RC
通讯作者：
Wuerz, RC
影响因子：
4.4
作者：
Wuerz, RC;Milne, LW;Gilboy, N
通讯作者：
Gilboy, N